Our Milestones
2013
Long term partnership signed with Novartis India Limited for exclusive marketing rights of Diclofenac TPM Gel (Voveran TPM Gel) for India2013
Break through development of Diclofenac 75 mg / ml injection using patented technology and assigned exclusive marketing rights to Novartis India Limited under their flagship brand Voveran 75 mg / ml Injection2006
Themis Joint Venture Richter Themis Medicare (India) Pvt. Ltd. commences production2006
THEMISEALTM the unique stops bleeding gel enters the European market.2006
Themis Medicare commences operations of its state-of-the-art formulation manufacturing facility at Haridwar.2002
Themis Medicare develops and introduces SEPGARDTM a unique wound healing agent FIRST TIME IN INDIA.2001
Themis Chemicals RENAMED THEMIS MEDICARE LIMITED1999
Launch of E MALTM, Alpha Beta Arteether, a THEMIS-CDRI product by the Prime Minister Shri Atal Behari Vajpayee, Prime Minister of India on Technology Day1998
Indigenously develops Simvastatin for the first time in Asia1985
Themis Chemicals produces RIFAMPICIN for the FIRST TIME in India1976
Themis Chemicals is the Second Company in the world and FIRST Company in India to produce Ethambutol Dihydrochloride.1971
Themis Chemicals became the Second Company in the world and First Company in India to produce Vitamin B12 by non-sterile fermentation.1969
Establishment of Themis Chemicals (now Themis Medicare) in joint partnership with GEDEON Richter Ltd. , Hungary
About Us
We want to take the world from pain to pain-free parentals through pain free work on dedicated innovations. Emal – the first in the world injectable against critical malaria, Etojet – the worlds first painless Etrocoxib injection and a first of its kinds injectable.
Diclofenac sodium for pain relief, are all a result of pursuit of ideas taken to their full potential. Our aim is to make disease management easier and painless for both patients and healthcare professionals.
Latest News
- Intimation under regulation 39(3) 9f Securities and Exchange Board of India (Listing Obligations and Disclosure Reguirements) Regulation, 2015 I“SEBI (LODR) Regulations, 2015″] 02/Apr/2019
- Change in directors of company 27/Mar/2019
- lntimation under regulation 39(3) of Securities and Exchanae Board of India (Listinq Obligations and Disclosure Requirements) Requlation, 2015 [“SEBI (LODR) Regulations, 2015″] 07/Mar/2019
- Intimation of Resolution by circulation passed by Board of Directors. 02/Mar/2019
- Outcome of Board Meeting – 08 Feb 2019 08/Feb/2019
View All
Contact Us
11/12, Udyog Nagar,
S. V. Road, Goregaon (W),
Mumbai- 400104.
Phone: +91.22.67607080
Email: info@themismedicare.com
Website: http://www.themismedicare.com